Biotech group Priothera signs €17.5m EIB loan
Dublin-headquartered Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator drug mocravimod,...
Dublin-headquartered Priothera, a late-clinical stage biotechnology company pioneering the development of its S1P receptor modulator drug mocravimod,...